Cargando…
Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance
The world is fighting the COVID-19 outbreak and health workers, including inflammatory bowel diseases specialists, have been challenged to address the specific clinical issues of their patients. We hereby summarize the current literature in the management of inflammatory bowel disease (IBD) patients...
Autores principales: | Queiroz, Natália Sousa Freitas, Barros, Luísa Leite, de Azevedo, Matheus Freitas Cardoso, Oba, Jane, Sobrado, Carlos Walter, de Sousa Carlos, Alexandre, Milani, Luciane Reis, Sipahi, Aytan Miranda, Damião, Aderson Omar Mourão Cintra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade de Medicina / USP
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153358/ https://www.ncbi.nlm.nih.gov/pubmed/32321117 http://dx.doi.org/10.6061/clinics/2020/e1909 |
Ejemplares similares
-
Recovery from COVID-19 Pneumonia in a Patient with Acute Severe Colitis
por: Garcia, Karoline Soares, et al.
Publicado: (2020) -
Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients
por: Martins, Camilla de Almeida, et al.
Publicado: (2023) -
Active tuberculosis in inflammatory bowel disease patients: a
case–control study
por: Freitas Cardoso de Azevedo, Matheus, et al.
Publicado: (2023) -
Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction—A Prospective Trial
por: Garcia, Karoline Soares, et al.
Publicado: (2023) -
Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review
por: Damião, Adérson Omar Mourão Cintra, et al.
Publicado: (2019)